Chinese biotech stocks hit by a double whammy, which means it’s time to buy By: MarketWatch November 30, 2018 at 08:53 AM EST The decline in biotech stocks is more about investors fleeing a high-beta group in a risk-off environment. Read More >> Related Stocks: Alibaba Group Holding Ltd Alphabet-A Alphabet-C Amazon.com Apple Baidu.com SP ADR Beigene Ltd ADR Casi Pharmaceuticals Inc Facebook JPMorgan Chase & Co Loncar China Biopharma ETF S&P Biotech SPDR Tencent Holdings ADR